Breast Cancer Treatment: Understanding the Options and Making Informed Decisions

A breast cancer diagnosis can bring a difficult period of uncertainty. Alongside the emotional impact, patients are often introduced to unfamiliar medical terms, diagnostic results, and treatment recommendations. They may need to make decisions about surgery, chemotherapy, radiation therapy, hormone therapy, or targeted medicines, sometimes within a relatively short period.

Although the treatment journey can feel complicated, understanding how different therapies work and why they may be recommended can help patients participate more confidently in their care.

Breast cancer treatment is not the same for everyone. Decisions depend on the type of cancer, its stage, tumour characteristics, the patient’s overall health, and individual preferences. A coordinated approach involving different medical specialists can help ensure that treatment addresses both the cancer and the patient’s broader needs.

Why Breast Cancer Is Not One Single Disease

Breast cancer describes several different types of cancer that develop in breast tissue. These cancers can behave differently and respond to different treatments.

One important distinction involves hormone receptor status. Some breast cancers have receptors for oestrogen or progesterone, meaning their growth may be influenced by these hormones. Other cancers are hormone receptor-negative.

Another important characteristic is HER2 status. HER2-positive breast cancers have higher levels of a protein that can promote cancer cell growth. These cancers may respond to medicines designed to target HER2.

Triple-negative breast cancer does not have oestrogen or progesterone receptors and does not overexpress HER2. Its treatment approach can therefore differ from that of hormone receptor-positive or HER2-positive disease.

Dr. Aneeqah Din Muhammad, a medical and health writer at MyBCTeam, explains, “Understanding the biological characteristics of breast cancer is essential because two patients with the same diagnosis may need very different treatment plans. Tumor biology, extent, receptor status, stage, and individual health factors all contribute to tailor the treatment plan made by the care team.”

These distinctions help explain why a treatment that works well for one patient may not be appropriate for another.

The Importance of Staging and Diagnostic Testing

Before treatment recommendations are finalized, doctors need to understand the extent and characteristics of the cancer.

Diagnostic evaluation commonly includes imaging, such as mammography, ultrasound, or less often, MRI breast when appropriate. A biopsy is always needed to confirm whether a suspicious finding is cancerous and to determine important tumour characteristics.

Staging helps describe the size of the tumour, whether nearby lymph nodes are involved, and whether cancer has spread to other parts of the body. The stage provides important information for treatment planning, although tumour biology and other clinical factors also matter.

Pathology reports may include information about:

  • The type of breast cancer.
  • Tumour size and grade.
  • Oestrogen and progesterone receptor status.
  • HER2 status.
  • Whether lymph nodes contain cancer cells.
  • Other findings that may influence treatment decisions, such as proliferation rate.

Some patients may also be offered genomic testing to help estimate the likelihood of recurrence or predict whether certain treatments, such as chemotherapy, are likely to provide additional benefit. These tests are appropriate only for selected patients, more commonly for patients with a strong family history, and depend on the cancer’s characteristics.

Understanding the Role of Chemotherapy

Chemotherapy uses medicines to destroy cancer cells or prevent them from growing and dividing. It may be recommended before or after surgery, depending on the patient’s diagnosis and treatment goals.

When chemotherapy is given before surgery, it is called neoadjuvant chemotherapy. It can be used to shrink a tumour, potentially making it possible to preserve breast during surgery, and allow doctors to assess how the cancer responds to treatment.

When given after surgery, chemotherapy is called adjuvant chemotherapy. Its purpose is to reduce the risk of cancer returning by treating cancer cells that may remain in the body but cannot be detected through routine testing.

A small fraction of patients might even be spared from chemotherapy. The decision depends on factors such as tumour size, lymph node involvement, receptor status, tumour grade, genomic test results when appropriate, and most importantly, overall health of the patient.

Matthew Kurian, Medical Oncologist at St. Elizabeth Healthcare, explains, “Chemotherapy decisions should reflect the biology and stage of the cancer as well as the patient’s individual circumstances. The goal is to identify when chemotherapy is likely to provide meaningful benefit and select a treatment approach that balances effectiveness with potential side effects.”

Patients should ask their oncology team why chemotherapy is being recommended, what benefits are expected, and which side effects may require monitoring.

Hormone Therapy and Targeted Treatments

For hormone receptor-positive breast cancer, endocrine therapy can play an important role in reducing the risk of recurrence or controlling advanced disease.

These medicines work by lowering oestrogen levels or blocking the effects of oestrogen on cancer cells. Depending on the patient’s age, menopausal status, diagnosis, and treatment history, options may include tamoxifen, aromatase inhibitors, or ovarian function suppression.

HER2-positive breast cancer may be treated with targeted medicines that interfere with HER2 signalling. These treatments have significantly expanded the options available for patients with this subtype.

Other targeted therapies may be appropriate for selected cancers with specific molecular characteristics or inherited genetic changes.

Immunotherapy may also be used in certain settings, particularly for some patients with triple-negative breast cancer. Its suitability depends on the disease stage, treatment setting, and relevant testing.

These treatments demonstrate why understanding tumour biology is central to modern breast cancer care.

Why Radiation Therapy May Be Recommended

Radiation therapy uses high-energy radiation to destroy cancer cells in a specific area. It is commonly used after breast-conserving surgery and may also be recommended after mastectomy for selected patients.

The purpose is to reduce the risk of cancer returning in the breast or surrounding region. Recommendations depend on factors such as tumour size, lymph node involvement, surgical findings, and other clinical characteristics.

Treatment schedules vary. Some patients receive shorter courses of radiation, while others need a different schedule based on their individual circumstances.

Patients should discuss the expected benefits, possible skin changes, fatigue, and other potential side effects with their radiation oncology team.

The Value of a Multidisciplinary Care Team

Breast cancer treatment often involves several specialists. A surgical oncologist may evaluate surgical options, while a medical oncologist considers chemotherapy, endocrine therapy, immunotherapy, and targeted medicines. A radiation oncologist assesses whether radiation is appropriate.

Radiologists, pathologists, nurses, genetic counselors, rehabilitation professionals, and other specialists may also contribute.

This collaborative approach helps ensure that decisions are based on a comprehensive understanding of the cancer rather than a single test or treatment option.

Patients can benefit from asking how different specialists coordinate recommendations and whether their case will be reviewed by a multidisciplinary team.

Managing Side Effects During Treatment

Treatment can affect patients in different ways. Chemotherapy may cause fatigue, nausea, changes in blood counts, hair loss, or an increased risk of infection. Hormone therapy may cause hot flashes, joint discomfort, or other menopausal symptoms. Radiation can cause skin irritation and tiredness.

Side effects vary according to the treatment and the individual. Not everyone experiences the same symptoms, and many side effects can be managed with supportive medicines or adjustments to care.

Patients should report new or worsening symptoms rather than waiting until the next appointment. Fever during chemotherapy, for example, may require urgent medical assessment because some treatments can reduce the body’s ability to fight infection.

Supportive care, nutrition guidance, physical activity when appropriate, and emotional support can also help patients manage the demands of treatment.

Questions Patients Can Ask Before Starting Treatment

A breast cancer diagnosis can generate many questions. Writing them down before appointments can help patients make better use of conversations with their care team.

Useful questions include:

  • What type and stage of breast cancer do I have?
  • What do my hormone receptor and HER2 results mean?
  • What is the goal of each recommended treatment?
  • Are there alternatives, and how do their benefits compare?
  • What side effects should I expect?
  • Will I need genetic or genomic testing?
  • How will treatment affect my daily activities?
  • Whom should I contact if I develop concerning symptoms?

Patients may also wish to bring a trusted family member or friend to appointments, particularly when discussing complex treatment decisions.

Moving Forward With a Clearer Treatment Plan

Breast cancer treatment has become increasingly individualized. Advances in pathology, imaging, genomic testing, chemotherapy, hormone therapy, and targeted medicines allow clinicians to tailor care to the characteristics of each cancer.

Understanding the purpose of each treatment can make the process less overwhelming. Patients do not need to know every medical detail before beginning care, but they should have opportunities to ask questions, understand their options, and discuss their priorities.

A clear treatment plan, supported by communication between specialists and the patient, can help make the breast cancer journey more informed and manageable.